Neil E. Kay

31.3k citations
619 papers · 27.2k · 7 hit papers · h-index 87

Impact in

  • Genetics top 0.01%
    • Chronic Lymphocytic Leukemia Research
  • Hematology top 0.2%
    • Multiple Myeloma Research and Treatments
    • Acute Myeloid Leukemia Research

Papers in

    • Chronic Lymphocytic Leukemia Research 458
    • Multiple Myeloma Research and Treatments 28
    • Blood groups and transfusion 11

Neil E. Kay

597 papers receiving 26.2k citations

Neil E. Kay's Hit Papers

Long-term outcomes for ibrutinib–rituximab and chemoimmunotherapy in CLL: updated results of the E1912 trial 2022 · 175 citations
1750+10+20Years since publication5001k1.5k

Peers

Neil E. Kay
Comparison fields: 5 of 146
  • Genetics 15k
  • Hematology 2.8k
  • Pathology and Forensic Medicine 2.5k
  • Oncology 2k
  • Immunology 1.7k
Replace Jennifer R. Brown with:
Jennifer R. Brown United States
Marinus H. J. van Oers Netherlands
A. V. Hoffbrand United Kingdom
Maher X. Albitar United States
Tadeusz Robak Poland
Carlos Bueso-Ramos United States
Christian Buske Germany
Luigi Maria Larocca Italy
Elisabeth M. Paietta United States
Zeev E. Estrov United States
Neil E. Kay relative to Jennifer R. Brown United States Jennifer R. Brown's profile →
Citations per field
00.5×1.5×1.9×
Jennifer R. Brown · 1×
Citations per year

Countries citing papers authored by Neil E. Kay

Since Specialization
Citations

This map shows the geographic impact of Neil E. Kay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neil E. Kay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neil E. Kay more than expected).

Fields of papers citing papers by Neil E. Kay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neil E. Kay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neil E. Kay. The network helps show where Neil E. Kay may publish in the future.

Co-authors

The 25 scholars most cited alongside Neil E. Kay, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Neil E. Kay Line = papers co-authored together Neil E. Kay links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 619 papers — load more, or switch the sort, to bring in the rest.

#Work
1
National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment
Hit paper breakdown →
19961587
2
Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia
Hit paper breakdown →
20141384
3
Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia
Hit paper breakdown →
2019608
4
GM-CSF inhibition reduces cytokine release syndrome and neuroinflammation but enhances CAR-T cell function in xenografts
Hit paper breakdown →
2018520
5
Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III Trial
Hit paper breakdown →
2021491
6
Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL
Hit paper breakdown →
2017362
7 1988339
8 2005318
9 2009280
10 2002276
11 2008265
12 2006245
13 2011238
14 2014221
15 2006206
16 2009203
17 2002197
18 2003197
19 2013196
20 2013189

About Neil E. Kay

Neil E. Kay is a scholar working on Genetics, Hematology, Immunology, Pathology and Forensic Medicine and Oncology, having authored 619 papers that have together received 27.2k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (458 papers), Multiple Myeloma Research and Treatments (28 papers), Lymphoma Diagnosis and Treatment (28 papers), CAR-T cell therapy research (18 papers), T-cell and B-cell Immunology (13 papers), Immune Cell Function and Interaction (12 papers), Blood groups and transfusion (11 papers) and Immune cells in cancer (8 papers). The work is most often cited by research in Genetics (15k citations), Hematology (2.8k citations), Pathology and Forensic Medicine (2.5k citations), Oncology (2k citations) and Immunology (1.7k citations). Neil E. Kay has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Tait D. Shanafelt, Diane F. Jelinek, Timothy G. Call, Clive S. Zent, Susan L. Slager, Michael R. Grever, Bruce D. Cheson, Martin M. Oken, Nancy D. Bone and Susan Marie Schwager. Their work appears in journals such as Blood, British Journal of Haematology, Leukemia, American Journal of Hematology and Leukemia Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact